Ken Fisher’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-27,485
Closed -$1.01M 829
2018
Q1
$1.01M Hold
27,485
﹤0.01% 568
2017
Q4
$1.03M Buy
27,485
+5,672
+26% +$289K ﹤0.01% 579
2017
Q3
$1.41M Sell
21,813
-9
-0% -$551 ﹤0.01% 532
2017
Q2
$1.18M Buy
21,822
+8,319
+62% +$443K ﹤0.01% 522
2017
Q1
$753K Buy
13,503
+2,785
+26% +$146K ﹤0.01% 529
2016
Q4
$527K Sell
10,718
-3,138
-23% -$173K ﹤0.01% 559
2016
Q3
$831K Sell
13,856
-5,184
-27% -$278K ﹤0.01% 527
2016
Q2
$845K Sell
19,040
-36
-0.2% -$1.57K ﹤0.01% 526
2016
Q1
$903K Buy
19,076
+36
+0.2% +$1.41K ﹤0.01% 522
2015
Q4
$1.3M Hold
19,040
﹤0.01% 497
2015
Q3
$863K Buy
+19,040
New +$1.11M ﹤0.01% 513

Other funds holding PRTA

Ken Fisher's PRTA Position: Q2 2018 in Review

Ken Fisher sold out of Prothena Corp (PRTA) in Q2 2018, closing a stake of 27,485 shares — an estimated $1.01M sold.

Ken Fisher first reported a position in PRTA in Q3 2015 and held it in 11 quarters. The position peaked at $1.41M in Q3 2017. 125 funds tracked by Wall St. Rank hold PRTA as of Q2 2018.

  • Ken Fisher reported no remaining Prothena Corp position as of Q2 2018 after selling out during the quarter.
  • Ken Fisher sold 27,485 Prothena Corp shares in Q2 2018, an estimated $1.01M.
  • Ken Fisher first reported a position in Prothena Corp in Q3 2015 and held it in 11 quarters.
  • Ken Fisher's Prothena Corp position peaked at $1.41M in Q3 2017.
  • 125 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2018.

Based on Fisher Asset Management's 13F filing for Q2 2018, filed 9 Jul 2018.